TB
Think Bioscience
United States · Biotech
Develops small molecule drugs for historically challenging drug targets
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $55M | AV8 Ventures — Role not disclosedBuff Gold Ventures — Role not disclosedCE-Ventures — Role not disclosedCU Innovations — Role not disclosedInnovation Endeavors — Role not disclosedJanus Henderson Investors — Role not disclosedMBX Capital — Role not disclosedRegeneron Ventures — Role not disclosedT.A. Springer — Role not disclosedYK Bioventures — Role not disclosed |